Phage Therapy Market Gains Momentum in Food Safety and Human Health

InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Phage Therapy Market- by Product(Oral, External Application and Surgical Treatment), Application (Human Medicine, Veterinary Science and Others (Agriculture, dentistry, etc.)), Trends, Industry Competition Analysis, Revenue and Forecast To 2034."

Global Phage Therapy Market is expected to grow at an 20.50% CAGR during the forecast period for 2025-2034.

Get Free Access to Demo Report, Excel Pivot and ToC: https://www.insightaceanalytic.com/request-sample/1094

Bacteriophages, commonly referred to as phage therapy, are viruses that selectively infect specific bacterial strains without affecting beneficial microbiota within the human body. Due to their composition-primarily nucleic acids and proteins-phages are inherently non-toxic and exhibit minimal side effects. They may be administered via various routes, including oral intake, topical application, or surgical intervention. Their adaptability in formulation enables integration with conventional antibiotics, offering synergistic therapeutic benefits.

The growth of the global phage therapy market is driven by several key factors, including increasing applications in the food and beverage industry, the ability of phages to target specific pathogenic bacteria, extensive research and development initiatives, and the rising incidence of antimicrobial resistance (AMR). Additionally, the prevalence of foodborne illnesses and the escalating threat of antibiotic resistance-largely attributed to the overuse and misuse of antibiotics-further underscores the urgency of developing alternative treatments such as bacteriophages. Phage therapy also presents a viable option for patients with allergies to traditional antibiotics, as allergic reactions to phages are rare.

Despite its promise, the market faces notable challenges. These include a shortage of skilled professionals and technicians specializing in phage research and therapy, as well as the high failure rates associated with drug development and commercialization. However, the emergence of advanced bacteriophage platforms and a growing patient base-particularly in developing economies-are creating substantial growth opportunities within the market.

North America is expected to hold a significant share of the phage therapy market, driven by growing consumer interest in probiotic supplements aimed at enhancing gut health through phage-based solutions. Leading regional manufacturers are actively expanding their product portfolios to include advanced phage therapy technologies.

Expert Knowledge, Just a Click Away: https://calendly.com/insightaceanalytic/30min?month=2025-04

Meanwhile, the Asia-Pacific region is anticipated to witness considerable growth during the forecast period. The region is experiencing heightened interest in phage therapy as a result of rising cases of infections caused by multidrug-resistant bacteria such as Staphylococcus aureus. Increased collaboration between pharmaceutical companies and government research institutions is accelerating innovation and development in this area, reinforcing the region's potential as a major hub for phage therapy advancement.

Major market players operating in the Phage Therapy market include
Armata Pharmaceuticals, Inc., Adaptive Phage Therapeutics, AmpliPhi Biosciences, BiomX (MBcure Ltd.), C3J Therapeutics, Enbiotix, Eligo Bioscience, Intralytix, Inc., InnoPhage, iNtODEWorld, Locus Biosciences, MicroPhage, Inc., Phage International, PhagoMedBiopharma GmbH, PherecydesPharma SA, TechnoPhage, Phagelux, SNIPR BIOME, and Microgen Russia.

Recent collaborations and agreements in the market:
• In 2020, a new e-Commerce site for Optibac probiotics was launched by Ridgeway, a digital firm, to increase consumer compliance and repeat purchases of phage therapy supplements.
• In 2019, IntraLytix Inc. created various innovative phage therapies against Shigella intended for human ingestion and numerous phage preparations for directly eliminating harmful bacteria.

Unlock Your GTM Strategy: https://www.insightaceanalytic.com/customisation/1094

Market Segments
Global Phage Therapy Market, by Product, 2022-2028 (Value US$ Mn)
• Oral
• External Application
• Surgical Treatment
Global Phage Therapy Market, by Application, 2022-2028 (Value US$ Mn)
• Human Medicine
• Veterinary Science
• Others (Agriculture, dentistry, etc.)
Global Phage Therapy Market, by Region, 2022-2028 (Value US$ Mn)
• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa
North America Phage Therapy Market, by Country, 2022-2028 (Value US$ Mn)
• U.S.
• Canada
Europe Phage Therapy Market, by Country, 2022-2028 (Value US$ Mn)
• Germany
• France
• Italy
• Spain
• Russia
• Rest of Europe
Asia Pacific Phage Therapy Market, by Country, 2022-2028 (Value US$ Mn)
• India
• China
• Japan
• South Korea
• Australia & New Zealand
Latin America Phage Therapy Market, by Country, 2022-2028 (Value US$ Mn)
• Brazil
• Mexico
• Rest of Latin America
Middle East & Africa Phage Therapy Market, by Country, 2022-2028 (Value US$ Mn)
• GCC Countries
• South Africa
• Rest of Middle East & Africa

Why should buy this report:
• To receive a comprehensive analysis of the prospects for the global Phage Therapy market
• To receive an industry overview and future trends of thePhage Therapy market
• To analyzethe Phage Therapy market drivers and challenges
• To get information on the Phage Therapy market value (US$ Mn) forecast to 2028
• Significant investments, mergers &acquisitions in the Phage Therapy marketindustry

Read Overview Report- https://www.insightaceanalytic.com/report/global-phage-therapy-market-/1094

About Us:
InsightAce Analytic is a market research and consulting firm that enables clients to make strategic decisions. Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to expand businesses. We help clients gain competitive advantage by identifying untapped markets, exploring new and competing technologies, segmenting potential markets and repositioning products. Our expertise is in providing syndicated and custom market intelligence reports with an in-depth analysis with key market insights in a timely and cost-effective manner.

Contact us:
InsightAce Analytic Pvt. Ltd.
Visit: www.insightaceanalytic.com
Tel : +1 607 400-7072
Asia: +91 79 72967118
info@insightaceanalytic.com

This release was published on openPR.